Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Telomere shortening limits the number of cell divisions of primary human cells and might affect the regenerative capacity of organ systems during aging and chronic disease. To test whether the telomere hypothesis applies to human cirrhosis, the telomere length was monitored in cirrhosis induced by a broad variety of different etiologies. Telomeres were significantly shorter in cirrhosis compared with noncirrhotic samples independent of the primary etiology and independent of the age of the patients. Quantitative fluorescence in situ hybridization showed that telomere shortening was restricted to hepatocytes whereas lym‐phocytes and stellate cells in areas of fibrosis had significantly longer telomere reserves. Hepatocyte‐specific telomere shortening correlated with senescence‐associated p‐galactosidase staining in 84% of the cirrhosis samples, specifically in hepatocytes, but not in stellate cells or lymphocytes. Hepatocyte telomere shortening and senescence correlated with progression of fibrosis in cirrhosis samples. This study demonstrates for the first time that cell type‐specific telomere shortening and senescence are linked to progression of human cirrhosis. These findings give a novel explanation for the pathophysiology of cirrhosis, indicating that fibrotic scarring at the cirrhosis stage is a consequence of hepatocyte telomere shortening and senescence. The data imply that future therapies aiming to restore regenerative capacity during aging and chronic diseases will have to ensure efficient targeting of specific cell types within the affected organs.—Wiemann, S. U., Satyanarayana, A., Tsahuridu, M., Tillmann, H. L., Zender, L., Klempnauer, J., Flemming, P., Franco, S., Blasco, M. A., Manns, M. P., Rudolph, K. L. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J. 16, 935–942 (2002)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Telomere shortening has been implicated in hepatocyte senescence94 and in disease progression in patients with liver cirrhosis95.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [94]
In the citing paper
“Although less is known about hepatocyte senescence in humans than in mice, senescence-associated markers such as SA-β-gal staining have been identified in human cirrhotic livers160.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [160]
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“Senescence-associated -Gal staining was performed as described previously (18).”
BackgroundMethodTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750 · cited 1×
“Continuous shortening of telomeres during each cell division limits the life span of primary human cells in vitro (6).”
BackgroundHistological grading and staging of chronic hepatitis
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,029 · cited 3×
“Cirrhosis samples were grouped into samples with mild fibrosis and samples with severe fibrosis according to the Ishak criteria (19).”
MethodInfluentialStructure and function of telomeres
Blackburn, E. H. (1991) · Nature · doi:10.1038/350569a0 · Cited by 3,596
The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
Flier, J. S., Underhill, L. H., & Friedman, S. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282508 · Cited by 1,432
p53- and ATM-Dependent Apoptosis Induced by Telomeres Lacking TRF2
Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., & de Lange, T. (1999) · Science · doi:10.1126/science.283.5406.1321 · Cited by 1,086 · cited 1×
“The tumor suppressor p53 has been identified as a downstream target of short dysfunctional telomeres in mouse (34) and human cells (35).”
BackgroundChin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979
Telomere Shortening Is Associated with Cell Division in Vitro and in Vivo
Allsopp, R. C., Chang, E., Kashefi-Aazam, M., Rogaev, E. I., Piatyszek, M. A., Shay, J. W., & Harley, C. B. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1306 · Cited by 533 · cited 2×
“It is still a matter of debate to what extent telomere shortening affects organo-pathophysiology during aging (7) or chronic diseases that induce elevated rates of cell turnover (8–11).”
BackgroundTelomere dysfunction and evolution of intestinal carcinoma in mice and humans
Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A. (2001) · Nature Genetics · doi:10.1038/88871 · Cited by 527 · cited 1×
“It has been shown that telomere shortening inhibits tumorigenesis in mTERC / mice that retain functional p53 (17, 32, 33).”
BackgroundSelf-citationCurrent Protocols in Cell Biology
(2001) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471143030 · Cited by 502
Research works printed but not linked: 1
- Rudolph K. L., 2001, Telomeres and telomerase in experimental liver cirrhosis, The Liver Biology and Pathobiology, 1000
Cited by
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Self-citationCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Self-citationHepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1934 · Cited by 1,979
Telomeres and human disease: ageing, cancer and beyond
Blasco, M. A. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1656 · Cited by 1,434
Self-citationSenescence and aging: Causes, consequences, and therapeutic avenues
McHugh, D., & Gil, J. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201708092 · Cited by 1,233
Mechanisms of HBV-induced hepatocellular carcinoma
Levrero, M., & Zucman-Rossi, J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.021 · Cited by 1,052
Cellular senescence drives age-dependent hepatic steatosis
Ogrodnik, M., Miwa, S., Tchkonia, T., Tiniakos, D., Wilson, C. L., Lahat, A., Day, C. P., Burt, A., Palmer, A., Anstee, Q. M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15691 · Cited by 1,044
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
Dewidar, B., Meyer, C., Dooley, S., & Meindl-Beinker, A. N. (2019) · Cells · doi:10.3390/cells8111419 · Cited by 837
“In line, cellular senescence occurs in mouse and human liver fibrosis [249,250].”
BackgroundIMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS
Guidotti, L. G., & Chisari, F. V. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100230 · Cited by 811
Telomere dysfunction in ageing and age-related diseases
Rossiello, F., Jurk, D., Passos, J. F., & d’Adda di Fagagna, F. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00842-x · Cited by 754
Senescence and immortalization: Role of telomeres and telomerase
Shay, J. W., & Wright, W. E. (2005) · Carcinogenesis · doi:10.1093/carcin/bgh296 · Cited by 610
Telomere length, stem cells and aging
Blasco, M. A. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.38 · Cited by 747
Self-citationHow stem cells age and why this makes us grow old
Sharpless, N. E., & DePinho, R. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2241 · Cited by 743
Liver regeneration and repair: Hepatocytes, progenitor cells, and stem cells
Fausto, N. (2004) · Hepatology · doi:10.1002/hep.20214 · Cited by 720
DNA damage response and cellular senescence in tissues of aging mice
Wang, C., Jurk, D., Maddick, M., Nelson, G., Martin‐Ruiz, C., & Von Zglinicki, T. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00481.x · Cited by 696
“Examples are vascular aging and atherosclerosis (Fenton et al., 2001; Vasile et al., 2001; Minamino et al., 2002), liver cirrhosis (Wiemann et al., 2002) and osteoarthritis (Martin & Buckwalter, 2002).”
BackgroundPathogenesis of liver cirrhosis
Zhou, W.-C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7312 · Cited by 627
Telomeres: history, health, and hallmarks of aging
Chakravarti, D., LaBella, K. A., & DePinho, R. A. (2021) · Cell · doi:10.1016/j.cell.2020.12.028 · Cited by 637
“Given that high ROS levels are associated with telomere shortening and are postulated to be drivers of tissue inflammation, even in the absence of genetic mutations in telomere-maintenance genes, telomere shortening and damage could be instrumental in driving various inflammatory diseases in older individuals without…”
BackgroundCellular senescence: a key therapeutic target in aging and diseases
Zhang, L., Pitcher, L. E., Yousefzadeh, M. J., Niedernhofer, L. J., Robbins, P. D., & Zhu, Y. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158450 · Cited by 631
Alveolar Cell Senescence in Patients with Pulmonary Emphysema
Tsuji, T., Aoshiba, K., & Nagai, A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1374oc · Cited by 527
“We therefore hypothesized that the increased senescence of alveolar type II cells as well as of endothelial cells compromises lung regenerative capacity, thereby accelerating the loss of alveolar architecture ( 2 , 3). Our finding of a significant correlation between decreased FEV1%predicted values and the level of al…”
BackgroundResultInfluentialThe Etiology of Hepatocellular Carcinoma and Consequences for Treatment
Sanyal, A. J., Yoon, S. K., & Lencioni, R. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-s4-14 · Cited by 517
Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice
Sacco, A., Mourkioti, F., Tran, R., Choi, J., Llewellyn, M., Kraft, P., Shkreli, M., Delp, S., Pomerantz, J. H., Artandi, S. E., et al. (2010) · Cell · doi:10.1016/j.cell.2010.11.039 · Cited by 512
A synopsis on aging—Theories, mechanisms and future prospects
da Costa, J. P., Vitorino, R., Silva, G. M., Vogel, C., Duarte, A. C., & Rocha-Santos, T. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.06.005 · Cited by 456
Telomeres, stem cells, senescence, and cancer
Sharpless, N. E., & DePinho, R. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20761 · Cited by 473
Hepatic progenitor cells of biliary origin with liver repopulation capacity
Lu, W.-Y., Bird, T. G., Boulter, L., Tsuchiya, A., Cole, A. M., Hay, T., Guest, R. V., Wojtacha, D., Man, T. Y., Mackinnon, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3203 · Cited by 479
Geronimus, A. T., Hicken, M. T., Pearson, J. A., Seashols, S. J., Brown, K. L., & Cruz, T. D. (2010) · Human Nature · doi:10.1007/s12110-010-9078-0 · Cited by 447
Liver stem cells and their implication in hepatocellular and cholangiocarcinoma
Roskams, T. (2006) · Oncogene · doi:10.1038/sj.onc.1209558 · Cited by 422
“Intruiguingly, mesenchymal cells like endothelial cells and hepatic stellate cells do not show this replicative senescence (Wiemann et al., 2002; Marshall et al., 2005).”
BackgroundSenNet recommendations for detecting senescent cells in different tissues
Suryadevara, V., Hudgins, A. D., Rajesh, A., Pappalardo, A., Karpova, A., Dey, A. K., Hertzel, A., Agudelo, A., Rocha, A., Soygur, B., et al. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00738-8 · Cited by 408
“Although less is known about hepatocyte senescence in humans than in mice, senescence-associated markers such as SA-β-gal staining have been identified in human cirrhotic livers 160 .”
DNA damage checkpoints in stem cells, ageing and cancer
Sperka, T., Wang, J., & Rudolph, K. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3420 · Cited by 393
Self-citationShortened Telomere Length Is Associated with Increased Risk of Cancer: A Meta-Analysis
Ma, H., Zhou, Z., Wei, S., Liu, Z., Pooley, K. A., Dunning, A. M., Svenson, U., Roos, G., Hosgood, H. D., Shen, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020466 · Cited by 376
Oncogene-Induced Cell Senescence — Halting on the Road to Cancer
Mooi, W. J., & Peeper, D. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062285 · Cited by 371
Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population
Rattan, P., Penrice, D. D., Ahn, J. C., Ferrer, A., Patnaik, M., Shah, V. H., Kamath, P. S., Mangaonkar, A. A., & Simonetto, D. A. (2022) · Hepatology Communications · doi:10.1002/hep4.1803 · Cited by 360
Acute-on-chronic liver failure: terminology, mechanisms and management
Sarin, S. K., & Choudhury, A. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.219 · Cited by 342
Telomerase: A target for cancer therapeutics
Shay, J. W., & Wright, W. E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00159-9 · Cited by 339
Durand, F., Levitsky, J., Cauchy, F., Gilgenkrantz, H., Soubrane, O., & Francoz, C. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.009 · Cited by 320
Epigenetic factors in aging and longevity
Gravina, S., & Vijg, J. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0730-7 · Cited by 329
Healing and Hurting: Molecular Mechanisms, Functions, and Pathologies of Cellular Senescence
Adams, P. D. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.021 · Cited by 326
Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease
Aravinthan, A., Scarpini, C., Tachtatzis, P., Verma, S., Penrhyn-Lowe, S., Harvey, R., Davies, S. E., Allison, M., Coleman, N., & Alexander, G. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.031 · Cited by 326
“Hepatocyte telomere mean fluorescent intensity (MFI), a validated measure of telomere length [24,25], was lower in patients with NAFLD compared with controls (553 vs.”
ResultChemistry in human telomere biology: structure, function and targeting of telomere DNA/RNA
Xu, Y. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00134a · Cited by 323
Hallmarks of Aging in the Liver
Hunt, N. J., Kang, S. W. (., Lockwood, G. P., Le Couteur, D. G., & Cogger, V. C. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.07.021 · Cited by 306
“[15,16] because hepatocytes are relatively resistant to replicative aging and the effects of telomere attrition [17].”
BackgroundChoi, J., Kim, H. J., Lee, J., Cho, S., Ko, M. J., & Lim, Y.-S. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.4070 · Cited by 282
“These data raise concern about the carcinogenic potential of entecavir even at clinical doses during longterm treatment, especially inpatientswith cirrhosiswhohave increased chromosomal instability of hepatocytes.(26,27) Nevertheless, given that HBV replication itself is a strong independent risk factor forHCC,assessi…”
BackgroundRetractedEffect of Cytotoxic Chemotherapy on Markers of Molecular Age in Patients With Breast Cancer
Sanoff, H. K., Deal, A. M., Krishnamurthy, J., Torrice, C., Dillon, P., Sorrentino, J., Ibrahim, J. G., Jolly, T. A., Williams, G., Carey, L. A., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju057 · Cited by 283
Self-citationThe role of telomeres and telomerase in cirrhosis and liver cancer
Nault, J.-C., Ningarhari, M., Rebouissou, S., & Zucman-Rossi, J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0165-3 · Cited by 239
Physiological and pathological consequences of cellular senescence
Burton, D. G. A., & Krizhanovsky, V. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1691-3 · Cited by 253
Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis
Ramachandran, P., Matchett, K. P., Dobie, R., Wilson-Kanamori, J. R., & Henderson, N. C. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0304-x · Cited by 253
Cellular senescence in vivo: Its relevance in ageing and cardiovascular disease
Erusalimsky, J. D., & Kurz, D. J. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.04.010 · Cited by 252
Cigarette Smoke Induces Senescence in Alveolar Epithelial Cells
Tsuji, T., Aoshiba, K., & Nagai, A. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0290oc · Cited by 241
Ramakrishna, G., Rastogi, A., Trehanpati, N., Sen, B., Khosla, R., & Sarin, S. K. (2013) · Liver Cancer · doi:10.1159/000343852 · Cited by 238
Senturk, S., Mumcuoglu, M., Gursoy-Yuzugullu, O., Cingoz, B., Akcali, K. C., & Ozturk, M. (2010) · Hepatology · doi:10.1002/hep.23769 · Cited by 238
Cellular Senescence: Molecular Mechanisms, In Vivo Significance, and Redox Considerations
Muller, M. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2104 · Cited by 238
Experimental models of hepatocellular carcinoma
Newell, P., Villanueva, A., Friedman, S. L., Koike, K., & Llovet, J. M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.008 · Cited by 222
The balancing act of the liver: tissue regeneration versus fibrosis
Cordero-Espinoza, L., & Huch, M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93562 · Cited by 219
James, E. L., Michalek, R. D., Pitiyage, G. N., de Castro, A. M., Vignola, K. S., Jones, J., Mohney, R. P., Karoly, E. D., Prime, S. S., & Parkinson, E. K. (2015) · Journal of Proteome Research · doi:10.1021/pr501221g · Cited by 231
Telomere length is reset during early mammalian embryogenesis
Schaetzlein, S., Lucas-Hahn, A., Lemme, E., Kues, W. A., Dorsch, M., Manns, M. P., Niemann, H., & Rudolph, K. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402400101 · Cited by 217
Self-citationMaejima, Y., Adachi, S., Ito, H., Hirao, K., & Isobe, M. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2007.00358.x · Cited by 224
Hallmarks of telomeres in ageing research
Shay, J., & Wright, W. (2007) · The Journal of Pathology · doi:10.1002/path.2090 · Cited by 211
Marshall, A., Rushbrook, S., Davies, S. E., Morris, L. S., Scott, I. S., Vowler, S. L., Coleman, N., & Alexander, G. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.09.076 · Cited by 205
Selman, M., & Pardo, A. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101393 · Cited by 211
Oh, B.-K., Kim, H., Park, H.-J., Shim, Y.-H., Choi, J., Park, C., & Park, Y. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.20.1.65 · Cited by 203
Cellular senescence in the glaucomatous outflow pathway
Liton, P. B., Challa, P., Stinnett, S., Luna, C., Epstein, D. L., & Gonzalez, P. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.06.005 · Cited by 195
Bleomycin induces cellular senescence in alveolar epithelial cells
Aoshiba, K., Tsuji, T., & Nagai, A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00011903 · Cited by 197
Constitutional telomerase mutations are genetic risk factors for cirrhosis
Calado, R. T., Brudno, J., Mehta, P., Kovacs, J. J., Wu, C., Zago, M. A., Chanock, S. J., Boyer, T. D., & Young, N. S. (2011) · Hepatology · doi:10.1002/hep.24173 · Cited by 188
“It has been reported previously that telomeres are shorter in cirrhotic than in noncirrhotic hepatocytes regardless of disease etiology.(27,28) Short telomeres in both hepatocytes and peripheral blood leukocytes indicate the constitutive essence of telomere attrition in cirrhosis and implicate short and dysfunctional…”
BackgroundTelomere shortening in human diseases
Kong, C. M., Lee, X. W., & Wang, X. (2013) · The FEBS Journal · doi:10.1111/febs.12326 · Cited by 194
Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma
Tümen, D., Heumann, P., Gülow, K., Demirci, C.-N., Cosma, L.-S., Müller, M., & Kandulski, A. (2022) · Biomedicines · doi:10.3390/biomedicines10123202 · Cited by 170
Critical Review of Clinical Trials of Bone Marrow Stem Cells in Liver Disease
Houlihan, D. D., & Newsome, P. N. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.040 · Cited by 191
Assessing cell and organ senescence biomarkers
de Jesus, B. B., & Blasco, M. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.247866 · Cited by 187
Self-citationAgeing, telomeres, senescence, and liver injury
Hoare, M., Das, T., & Alexander, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.009 · Cited by 181
“It has been described that HCV is associated with shortened intrahepatic telomeres [61] and both DM [114] and alcohol [115] are known to cause oxidative stress through mitochondrial dysfunction.”
BackgroundMethodA method for measuring the distribution of the shortest telomeres in cells and tissues
Lai, T.-P., Zhang, N., Noh, J., Mender, I., Tedone, E., Huang, E., Wright, W. E., Danuser, G., & Shay, J. W. (2017) · Nature Communications · doi:10.1038/s41467-017-01291-z · Cited by 163
Senescence in chronic liver disease: Is the future in aging?
Aravinthan, A. D., & Alexander, G. J. M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.030 · Cited by 174
Telomere Attrition Due to Infection
Ilmonen, P., Kotrschal, A., & Penn, D. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002143 · Cited by 171
Activation of stem cells in hepatic diseases
Bird, T. G., Lorenzini, S., & Forbes, S. J. (2008) · Cell and Tissue Research · doi:10.1007/s00441-007-0542-z · Cited by 170
Telomerase gene mutations are associated with cirrhosis formation
Hartmann, D., Srivastava, U., Thaler, M., Kleinhans, K. N., N'Kontchou, G., Scheffold, A., Bauer, K., Kratzer, R. F., Kloos, N., Katz, S.-F., et al. (2011) · Hepatology · doi:10.1002/hep.24217 · Cited by 173
Self-citationHIV, Age, and the Severity of Hepatitis C Virus–Related Liver Disease: A Cohort Study
Kirk, G. D., Mehta, S. H., Astemborski, J., Galai, N., Washington, J., Higgins, Y., Balagopal, A., & Thomas, D. L. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-9-201305070-00604 · Cited by 170
Jiang, H., Schiffer, E., Song, Z., Wang, J., Zürbig, P., Thedieck, K., Moes, S., Bantel, H., Saal, N., Jantos, J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801457105 · Cited by 169
Self-citationShortened telomeres in individuals with abuse in alcohol consumption
Pavanello, S., Hoxha, M., Dioni, L., Bertazzi, P. A., Snenghi, R., Nalesso, A., Ferrara, S. D., Montisci, M., & Baccarelli, A. (2011) · International Journal of Cancer · doi:10.1002/ijc.25999 · Cited by 167
Molecular pathogenesis of hepatocellular carcinoma
Wong, C., & Ng, I. O. L. (2008) · Liver International · doi:10.1111/j.1478-3231.2007.01637.x · Cited by 165
Zhang, F., Chen, X., Zhang, W., Dong, H., Xiang, S., Zhang, W., & Zhang, B. (2008) · Histopathology · doi:10.1111/j.1365-2559.2007.02929.x · Cited by 164
Telomeres and telomerase: A dual role in hepatocarcinogenesis
Satyanarayana, A., Manns, M. P., & Rudolph, L. K. (2004) · Hepatology · doi:10.1002/hep.20308 · Cited by 158
Self-citationTelomere shortening and ageing
Jiang, H., Ju, Z., & Rudolph, K. L. (2007) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-007-0480-0 · Cited by 165
Self-citationParacrine cellular senescence exacerbates biliary injury and impairs regeneration
Ferreira-Gonzalez, S., Lu, W.-Y., Raven, A., Dwyer, B., Man, T. Y., O’Duibhir, E., Lewis, P. J. S., Campana, L., Kendall, T. J., Bird, T. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03299-5 · Cited by 161
Aging by epigenetics—A consequence of chromatin damage?
Sedivy, J. M., Gowrishankar, B., & Adams, P. D. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.02.023 · Cited by 170
“Specifically, senescent cells and/or molecular markers of the senescent phenotype have been reported to increase in some aging tissues [40,41,64–69], and are linked to some age-associated tissue pathologies, such as osteoarthritis, atherosclerosis and liver cirrhosis [70–72].”
BackgroundFarazi, P. A., Glickman, J. N., Jiang, S., Yu, A., Rudolph, K. L., & DePinho, R. A. (2003) · PubMed · Cited by 201
Self-citationSatyanarayana, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg367 · Cited by 159
Self-citationShort Telomere Length and Breast Cancer Risk: A Study in Sister Sets
Shen, J., Terry, M. B., Gurvich, I., Liao, Y., Senie, R. T., & Santella, R. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3490 · Cited by 158
Early life stress and telomere length: Investigating the connection and possible mechanisms
Shalev, I. (2012) · BioEssays · doi:10.1002/bies.201200084 · Cited by 170
Djojosubroto, M. W., Chin, A. C., Go, N., Schaetzlein, S., Manns, M. P., Gryaznov, S., Harley, C. B., & Rudolph, L. K. (2005) · Hepatology · doi:10.1002/hep.20822 · Cited by 151
Self-citationPlentz, R. R., Park, Y. N., Lechel, A., Kim, H., Nellessen, F., Langkopf, B. H. E., Wilkens, L., Destro, A., Fiamengo, B., Manns, M. P., et al. (2007) · Hepatology · doi:10.1002/hep.21552 · Cited by 167
Self-citationWhen dormancy fuels tumour relapse
Santos-de-Frutos, K., & Djouder, N. (2021) · Communications Biology · doi:10.1038/s42003-021-02257-0 · Cited by 164
Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment
McQuitty, C. E., Williams, R., Chokshi, S., & Urbani, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.574276 · Cited by 146
“Senescence has been reported in hepatocytes in different liver diseases such as cirrhosis (62, 63) in cholangiocytes during primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) (64, 65, 66); and in HSCs in fibrosis (67).”
BackgroundSchaetzlein, S., Nalapareddy, K., Ju, Z., Lechel, A., Stępczyńska, A., Lilli, D. R., Clark, A. B., Rudolph, C., Kühnel, F., Wei, K., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.029 · Cited by 167
Self-citationTelomeres and Telomerase in Aging, Regeneration and Cancer
Djojosubroto, M. W., Choi, Y. S., Lee, H., & Rudolph, K. L. (2003) · Molecules and Cells · doi:10.1016/s1016-8478(23)13723-x · Cited by 172
Self-citationEpithelial Plasticity during Liver Injury and Regeneration
Gadd, V. L., Aleksieva, N., & Forbes, S. J. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.08.016 · Cited by 142
Zhang, D., Jiang, M., & Miao, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016789 · Cited by 146
Molecular signaling and genetic pathways of senescence: Its role in tumorigenesis and aging
Zhang, H. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20919 · Cited by 152
“Cells with characteristics of replicative senescence as determined by senescence associated b-galactosidase staining have also been detected to accumulate with age in vivo (Dimri et al., 1995; Paradis et al., 2001; Going et al., 2002; Wiemann et al., 2002).”
BackgroundMolecular pathology and age estimation
Meißner, C., & Ritz‐Timme, S. (2010) · Forensic Science International · doi:10.1016/j.forsciint.2010.07.010 · Cited by 135
“There are many chronic diseases which affect telomere length [49] such as anaemia, hypertension, coronary heart disease, chronic liver disease and others [71–74].”
BackgroundMolecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Ma, X., Huang, T., Chen, X., Li, Q., Liao, M., Fu, L., Huang, J., Yuan, K., Wang, Z., & Zeng, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02104-8 · Cited by 133
Plentz, R. R., Caselitz, M., Bleck, J. S., Gebel, M., Flemming, P., Kubicka, S., Manns, M. P., & Rudolph, K. L. (2004) · Hepatology · doi:10.1002/hep.20271 · Cited by 131
Self-citationHBV induced hepatocellular carcinoma and related potential immunotherapy
Jia, L., Gao, Y., He, Y., Hooper, J. D., & Yang, P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104992 · Cited by 140
Strategies for immortalization of primary hepatocytes
Ramboer, E., Craene, B. D., Kock, J. D., Vanhaecke, T., Berx, G., Rogiers, V., & Vinken, M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.046 · Cited by 138
Sasaki, M., Ikeda, H., Yamaguchi, J., Nakada, S., & Nakanuma, Y. (2008) · Hepatology · doi:10.1002/hep.22348 · Cited by 125
Metadata
- Authors
- WIEMANN, S. U., SATYANARAYANA, A., TSAHURIDU, M., TILLMANN, H. L., ZENDER, L., KLEMPNAUER, J., FLEMMING, P., FRANCO, S., BLASCO, M. A., MANNS, M. P., & RUDOLPH, K. L.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Department of Gastroenterology, Hepatology, and Endocrinology Medical School Hannover Germany
- Consejo Superior de Investigaciones Científicas (ES)
- Department of Immunology and Oncology Centro National de Biotecnologia/CSIC Madrid Spain
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2002-07
- Volume
- 16
- Issue
- 9
- Pages
- 935-942
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2166704790
- Cited by
- 527
- References
- 34
- Citations by year
- 2026: 4 · 2025: 15 · 2024: 22 · 2023: 23 · 2022: 20 · 2021: 28 · 2020: 35 · 2019: 17 · 2018: 29 · 2017: 22 · 2016: 24 · 2015: 18 · 2014: 30 · 2013: 20 · 2012: 20
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (Ru 745/2-1, SFB 265/C5)
- Deutsche Krebshilfe (10-1809-Ru1)
- Ministerio de Ciencia y Tecnología
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- telomere shortening, hepatocyte senescence, liver cirrhosis, liver fibrosis, senescence-associated β-galactosidase, hepatocytes, hepatic stellate cells, lymphocytes, telomere length, cirrhosis progression, regenerative capacity, aging
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, beta-Galactosidase, Child, Humans, Liver Cirrhosis, Middle Aged, Models, Biological, Biomarkers, Telomere, Cellular Senescence, Disease Progression, Hepatocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.